INDICATION-

Enhacement of Anesthsia during inductiion ( consult product literature for use in patients ndrgoing cardiac surgery), analgesia and sedation in ventilated , intensive care patients

Side effects-

commonly hypoxia, rarely asytole, AV block and convulsion also reported

CAUTIONS-

No  adjustment is necessary in renal impairment 

Dose-

Analgesia and enhancement at induction- by intravenous infusion- Adult- 30-60 microgram /lkg/hour with or without an initial dose by intravenous injection of 0.25- 1 microgram /kg over atleast 30 seconds

Assisted ventilation- analgesia, and enhancement during maintenance of anesthesia by intravenous infusion - Adult- 3-120micrigram/kg with or without innitial dose by intravenous injection of 0.25-1 microgram /kg over at least 30 seconds accordng to anesthetic technique in light anesthsia by 5 minutes

Product-

Remifentanil ( non propriety )

ULVA - GSK

Pregnancy- No information availablr

Breast feeding - avoid breast feeding for 24 hours after administration- present n milk in animal studiesi